New pill could offer relief for rare voice disorder
NCT ID NCT07041203
Summary
This early-stage study is testing a longer-acting oral medication called Lumryz to see if it can ease voice symptoms in people with spasmodic dysphonia and voice tremor. The study will involve 8 participants who have previously responded to a similar, shorter-acting drug. Researchers will measure how well and for how long the medication improves voice symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPASMODIC DYSPHONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.